There are currently two drugs that are being developed in the hope of helping people with celiac disease. The first, AT1001, is the drug that was used in the trial in which I participated in 2006. Trials are still ongoing and are conducted by Alba Therapeutics.
The second drug is ALV003 for which Alvine Pharmaceuticals is conducting trials. Yesterday there was a news update regarding this drug. Here are a couple of brief quotes.
“Alvine Pharmaceuticals, Inc., today announced proof of concept in a Phase
1 Trial of ALV003, an oral protease therapy in development to detoxify gluten,
intended for use by patients with celiac disease.”
“Results from these studies support the use of ALV003 as a drug to be taken
with meals to address unintentional gluten exposure.”
If you have celiac disease, I suggest you take a minute to read the entire article here:
Alvine Pharmaceuticals Reports Positive Results With ALV003